INCY vs TECH — Key Metrics
| Metric | INCY (INCYTE CORP) | TECH (BIO-TECHNE CORP) |
|---|---|---|
| Price | 121.35 | 72.47 |
| Market Cap | 24.6 Billion | 11.36 Billion |
| P/E (TTM) | 14.94 | 61.94 |
| P/B (Quarterly) | 4.151 | 5.385 |
| P/S (TTM) | 4.23 | 9.35 |
| Net Profit Margin (TTM) | 27.7 | 15.0 |
| Gross Margin (TTM) | 92.6 | 65.8 |
| ROE (TTM) | 29.6 | 8.9 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
INCY · INCYTE CORP
Greatly Outperform
TECH · BIO-TECHNE CORP
Greatly Underperform
Recommendation Summary
Stock INCY is projected to greatly outperform the market, stock TECH is projected to greatly underperform the market. Upfront Recommendation: INCY.
Financial Metrics
Prices delayed ~15 min
| INCY | Metrics | TECH |
|---|---|---|
| $121.35 | Price | $72.47 |
| — | Market Capitalization | — |
| 14.94 | Price to Earnings Ratio | 61.94 |
| 4.23 | Price to Sales | 9.35 |
| 12.81 | Price to FCF Ratio | 43.17 |
| 4.56 | Price to Gross Profit | 14.22 |
| 11.44 | Price to R&D | 119.92 |
| 4.08 | Price to Current Assets | 15.27 |